SUBSCRIPTION AGREEMENTSubscription Agreement • July 2nd, 2013 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), is dated as of June 26, 2013, by and between Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and the subscribers identified on Schedule 1 hereto, which may be amended from time to time prior to Closing (the “Subscribers”).
SECURITY AGREEMENTSecurity Agreement • July 2nd, 2013 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
This SECURITY AGREEMENT, dated as of June 26, 2013 (this “Agreement”), is among Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), each Subsidiary of the Company that becomes a party to this Agreement by execution and delivery of the form annexed hereto as Annex A and the Subsidiary Guaranty annexed thereto (each such Subsidiary, the “Guarantor” and together with the Company, the “Debtors”), Collateral Agents, LLC, as collateral agent (the “Collateral Agent”) for and the holders of the Company’s Secured Convertible Notes due December 26, 2013 which were issued on June 26, 2013, in the original aggregate principal amount of up to $7,000,000 (collectively, the “Notes”) (collectively, the “Secured Parties”).
ESCROW AGREEMENTEscrow Agreement • July 2nd, 2013 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
This Agreement is dated as of the 26th day of June, 2013 among Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), the subscribers listed on Schedule 1 hereto (“Subscribers”), and Grushko & Mittman, P.C. (the “Escrow Agent”):
INTERCREDITOR AGREEMENTIntercreditor Agreement • July 2nd, 2013 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
THIS INTERCREDITOR AGREEMENT (this "Agreement") dated as of June 26, 2013, among the parties whose names are subscribed on the signature page hereto as Junior Lenders (collectively, the “Junior Lenders”), the parties identified on Schedule A-1 hereto (collectively the “Senior Lenders”), and Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Borrower”).
